LA Mayor Signs Order to Restrict Flavored Tobacco Sales

Aug.25.2022
LA Mayor Signs Order to Restrict Flavored Tobacco Sales
Los Angeles bans flavored tobacco sales, effective January 2023, citing harm to public health and disproportionately affecting minority groups.

On June 13th, Los Angeles Mayor Eric Garcetti signed an ordinance to restrict the sale of menthol cigarettes and other flavored tobacco products. The ordinance will take effect on January 1, 2023. As of June 16th, 2022, the Smoke-Free Kids campaign reported that 127 local governments in California have passed restrictions on the sale of flavored tobacco products. At least 108 of those jurisdictions have restricted the sale of menthol cigarettes in addition to other flavored tobacco products.


In July, California Attorney General Rob Bonta joined a bipartisan coalition of state attorneys general calling on the US Food and Drug Administration (FDA) to adopt final regulatory standards to ban the production and sale of menthol cigarettes and flavored cigars in the US market. In a written statement, Bonta said, "Every day, millions of Californians smoke and begin down a dangerous path, leading to devastating health consequences." "There is no time to waste. We urge the FDA to swiftly finalize proposed regulations to ban menthol cigarettes and flavored cigars, which primarily harm young people and people of color. Any delay will only result in more lives lost.


Last year, the law exempting menthol cigarettes faced opposition from members of the Black Caucus, Mark Ridley-Thomas, Marqueece Harris Dawson, and Curren Price. They argued that studies have shown that African Americans are the most likely ethnic group to use menthol cigarettes, with a likelihood 25 times greater than that of white Americans.


Bonta has joined a coalition that includes attorneys general from Colorado, Connecticut, Delaware, Illinois, Pennsylvania, Idaho, Hawaii, Maine, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, North Carolina, Rhode Island, South Dakota, Vermont, Washington D.C. as well as Guam, Puerto Rico, and the U.S. Virgin Islands.


In a letter to the FDA, the Association of Attorneys General emphasized the need to remove these products from the market to protect public health and address the disproportionate and systemic impact on vulnerable minority communities.


The FDA should have taken action to ban menthol cigarettes and flavored cigars long ago, with sufficient scientific backing. They reference a study that found menthol cigarettes disproportionately harm vulnerable populations, particularly African Americans.


Overwhelming scientific evidence, including the FDA's own findings and statements, indicates that menthol cigarettes have a significant negative impact on public health, leading to increased smoking and tobacco use that result in more sickness and deaths.


A recent study published in the "Tobacco Control" journal found that mint-flavored cigarettes "caused over 10 million smokers and 378,000 premature deaths" between 1980 and 2018.


Mint flavoring masks the harsh taste of tobacco, which remains the primary reason young people start and become addicted to smoking - over half of adult smokers aged 18-34 use mint-flavored cigarettes.


In the LGBTQ+ community, among smokers with mental health issues, and in socioeconomically disadvantaged groups, the usage of menthol cigarettes is also high.


In August 2020, Governor Gavin Newsom signed Senate Bill 793, a bipartisan effort aimed at eliminating flavored electronic cigarettes, including candy and mint flavors, which he said "would addict our children." Last year, Newsom called on the FDA to ban mint-flavored cigarettes, saying it was "an important step in the right direction." In April 2021, Newsom urged the federal government to follow California's lead in protecting public health and promoting racial equality by banning menthol-flavored cigarettes. "For decades, Big Tobacco has targeted Black communities and profited from them by selling menthol cigarettes, making smoking-related illnesses the leading cause of death for African Americans in this country," he said.


The alliance stated in its letter that the proposed ban on menthol by the FDA is a crucial step in promoting health equity and protecting public health, and it will not significantly increase illegal trade.


Removing menthol cigarettes from the US market and banning flavors in cigars could potentially decrease smoking among young people, lead to better smoking cessation outcomes among adults, promote health equity, and benefit public health. This is according to a signed letter from 23 attorneys general representing various states and territories, who argue that inaction in these areas each year results in the loss of thousands of lives and has an adverse impact on the overall health of the public.


On the ballot for the November 8th election, Proposition 31 is a referendum on SB 793, aimed at lifting the current ban on the sale of flavored e-cigarettes, including mint and menthol, and flavored tobacco products in stores. A majority vote in favor will maintain the ban on flavored tobacco products, while a majority vote against will lift the ban.


Declaration


This article is compiled from third-party information and is intended only for industry exchange and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The compilation of this article is solely for internal industry research and communication purposes.


Due to limitations in translation ability, the translated article may not fully express the original text. Please refer to the original text for accuracy.


2FIRSTS maintains full alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Supreme Vape Revenue Rises 15% Despite UK Disposable Vape Ban
Supreme Vape Revenue Rises 15% Despite UK Disposable Vape Ban
UK consumer goods group Supreme said its vaping revenue rose 15% to £148.1 million in the year to March 31, 2026, despite the UK disposable vape ban taking effect during the period, while the company identified the Vaping Products Duty due in October as the next major industry milestone.
Regulations
Jul.03 by 2Firsts Perspectives
FDA Tobacco Proposal Signals Full-Chain Compliance Test for Global E-Cigarette Supply Chains
FDA Tobacco Proposal Signals Full-Chain Compliance Test for Global E-Cigarette Supply Chains
FDA’s proposed foreign tobacco establishment registration and product listing rule remains unfinished, but Accorto told 2Firsts it reflects a shift toward structured oversight similar to medical device and pharmaceutical compliance frameworks. For Chinese and global e-cigarette suppliers, U.S. market access is moving beyond product authorization toward full-chain compliance covering manufacturing, documentation, import control, distribution, retail and marketing discipline.
Special Report
Jul.09
Haypp Report Shows Nicotine Pouches Gaining Ground as a Vape Alternative in the UK
Haypp Report Shows Nicotine Pouches Gaining Ground as a Vape Alternative in the UK
According to Haypp’s 2026 UK Nicotine Report, nicotine pouches are increasingly replacing both cigarettes and vaping. The UK market grew sharply, with Haypp and Northerner reporting a 60% year‑on‑year sales increase in 2025. Notably, 40% of users adopted pouches to quit vaping, nearly matching the 43% who used them to stop smoking. This indicates pouches are expanding beyond traditional smoking cessation and gaining traction among adults seeking non‑inhalable nicotine alternatives.
Jul.01
UK Vaping Products Duty to Raise £565 Million by 2030/31
UK Vaping Products Duty to Raise £565 Million by 2030/31
The UK will introduce Vaping Products Duty on all vaping liquids from October 1, 2026, with government revenue forecast to rise from £135 million in 2026/27 to £565 million by 2030/31.
Jun.18
Data|China’s January-May 2026 Device Exports Rise 13% While Nicotine Product Exports Decline 6.9%
Data|China’s January-May 2026 Device Exports Rise 13% While Nicotine Product Exports Decline 6.9%
According to China Customs export data analyzed by 2Firsts, China’s vape export mix continued to evolve during January-May 2026. Exports of electronic vaporisation devices (HS 85434000) increased 13.00% year on year, supported by growth in both shipment volume and average export prices. Meanwhile, exports of nicotine-containing non-combustible products (HS 24041200) declined 6.89%, with lower shipment volumes partly offset by higher average export prices.
Special Report
Jun.30
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15